Opioid-Like Peptides and Ghrelin Mitigation of Bariatric Results Depends on Obesity Level

Endokrynologia Polska - Poland
doi 10.5603/ep.a2019.0044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

VM Media SP. zo.o VM Group SK

Related search

Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial

Radiology
Nuclear MedicineRadiologyImaging
2017English

Ghrelin, Diabetes and Obesity - Prospects for an Anti-Obesity Vaccine

JMS SKIMS
2011English

The Role of Ghrelin and Ghrelin O-Acyltransferase in Obesity: Targets for Treatment

English

Bariatric Surgery for Severe Obesity

TAJ: Journal of Teachers Association
2009English

Chronic Use of Opioid Medications Before and After Bariatric Surgery

JAMA - Journal of the American Medical Association
Medicine
2013English

Diabetes, Ghrelin and Related Peptides: From Pathophysiology to Vasculopathy

The Open Circulation & Vascular Journal
2012English

Dental Opioid Prescribing Practices and Risk Mitigation Strategy Implementation: Identification of Potential Targets for Provider-Level Intervention

Substance Abuse
MedicinePsychiatryMental Health
2015English

Endogenous Opioid Peptides and the Control of Pain1

Psychological Medicine
PsychiatryMental HealthApplied Psychology
1979English

Bariatric Surgery and Surgical Devices in Obesity Management

British Journal of Diabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy